Cargando…

Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma

The purpose of this study is to identify the optimal criteria of the radiotherapeutic parameters in patients with unresectable locally advanced hepatocellular carcinoma (HCC). 103 patients were enrolled in this study. All patients received RT delivered using the TomoTherapy Hi-Art system between Mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Seok Hyun, Jang, Hong Seok, Sung, Soo Yoon, Kang, Hye Jin, Lee, Sojung, Kay, Chul Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747233/ https://www.ncbi.nlm.nih.gov/pubmed/26510905

Ejemplares similares

Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2013)

Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma
por: Song, Jin Ho, et al.
Publicado: (2015)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2015)

Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
por: Lee, Sungmin, et al.
Publicado: (2018)

Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy
por: Son, Seok Hyun, et al.
Publicado: (2016)

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases
por: Tsao, May N, et al.
Publicado: (2005)

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
por: Combs, Stephanie E, et al.
Publicado: (2006)

Integrin Targeted Delivery of Radiotherapeutics
por: Liu, Zhaofei, et al.
Publicado: (2011)

Regulatory T Cells in Radiotherapeutic Responses
por: Schaue, Dörthe, et al.
Publicado: (2012)

Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2016)

Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2013)

Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2017)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas
por: Combs, Stephanie E, et al.
Publicado: (2007)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
por: Yang, Ping-Lian, et al.
Publicado: (2020)

Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients
por: Im, Jung Ho, et al.
Publicado: (2015)

To Optimize Radiotherapeutic Plans for Superior Tumor Coverage Predicts Malignant Glioma Prognosis and Normal Tissue Complication Probability
por: Kuo, Chun-Yuan, et al.
Publicado: (2022)

Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
por: Choe, Kevin S., et al.
Publicado: (2010)

Radiotherapeutic treatment options for oligotopic malignant liver lesions
por: Wust, Peter, et al.
Publicado: (2021)

Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Müllerian duct anomalies and their effect on the radiotherapeutic management of cervical cancer
por: Rastogi, Madhup, et al.
Publicado: (2013)

Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies
por: Deng, Guodong, et al.
Publicado: (2017)

Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
por: Wüstemann, Till, et al.
Publicado: (2016)

Radiotherapeutic management of brain tumours during the COVID-19 pandemic
por: Balakrishnan, Rajesh, et al.
Publicado: (2020)

The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma
por: Yoon, Hong In, et al.
Publicado: (2016)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma
por: Zhao, Shoujie, et al.
Publicado: (2020)

Machine Learning-Based Radiomics Predicts Radiotherapeutic Response in Patients With Acromegaly
por: Fan, Yanghua, et al.
Publicado: (2019)

Survival Disparities in the Radiotherapeutic Management of Lung Cancer by Regional Poverty Level
por: Mahase, Sean, et al.
Publicado: (2018)

Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect
por: Jing, Di, et al.
Publicado: (2022)

Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14–17)
por: Kim, Myungsoo, et al.
Publicado: (2017)

Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2015)

Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients
por: Yim, Sun Young, et al.
Publicado: (2022)

Case series illustrating the synergistic use of hydrogel spacer and MR-guidance to increase the radiotherapeutic index for localized prostate cancer
por: Sanmamed, Noelia, et al.
Publicado: (2019)

Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria
por: Zhang, Lan, et al.
Publicado: (2014)

Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
por: Cho, Young Youn, et al.
Publicado: (2021)

An approximate analytical solution of the Bethe equation for charged particles in the radiotherapeutic energy range
por: Grimes, David Robert, et al.
Publicado: (2017)

Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
por: Khan, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vh9l2rmng6aqgjagh36914iseb